Jong Hyuk Lee (Jong-Hyuk Lee)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Oxide Nanoparticles

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Bone marrow transplantation

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Silvia Park, Su-Yeon Bang, Daehun Kwag, Jong Hyuk Lee, Tong Yoon Kim, Joonyeop Lee, Gi June Min, Sung Soo Park, Seung-Ah Yahng, Young-Woo Jeon, Seung Hwan Shin, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1. Bone marrow transplantation 59 (6) (2024)
Su-Yeon Bang, Silvia Park, Daehun Kwag, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. Cancers 15 (6) (2023)
Jong Hyuk Lee, Byung-Sik Cho, Daehun Kwag, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je Kim
Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Jong Hyuk Lee, Byung-Sik Cho, Daehun Kwag, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong-Wook Lee, Hee-Je Kim
Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia. Cancers 15 (2) (2023)
Su-Yeon Bang, Silvia Park, Daehun Kwag, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Sung Soo Park, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. Cancers 15 (6) (2023)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)
Daehun Kwag, Byung-Sik Cho, Su-Yeon Bang, Jong Hyuk Lee, Gi-June Min, Sung Soo Park, Silvia Park, Sung Soo Park, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Sung-Eun Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee, Hee-Je Kim
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis. Blood cancer journal 12 (12) (2022)